177 related articles for article (PubMed ID: 38420407)
1. The global landscape of immune-derived lncRNA signature in colorectal cancer.
Zhang M; Wu Y; Mou J; Yao Y; Wen P; Liu X; Shang S; Kang X; Tian J; Liu Y; Lv E; Wang L
Heliyon; 2024 Feb; 10(4):e25568. PubMed ID: 38420407
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
3. Cross-Talk Between m
Song W; Ren J; Xiang R; Yuan W; Fu T
Front Immunol; 2022; 13():740960. PubMed ID: 35350786
[TBL] [Abstract][Full Text] [Related]
4. Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer.
Hu W; Wang Y; Fang Z; He W; Li S
Front Cell Dev Biol; 2021; 9():641891. PubMed ID: 33665192
[TBL] [Abstract][Full Text] [Related]
5. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
7. Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer.
Chen ZH; Lin YL; Chen SQ; Yang XY
World J Gastrointest Oncol; 2023 Nov; 15(11):1951-1973. PubMed ID: 38077636
[TBL] [Abstract][Full Text] [Related]
8. A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer.
Wang X; Zhou J; Xu M; Yan Y; Huang L; Kuang Y; Liu Y; Li P; Zheng W; Liu H; Jia B
Cancer Manag Res; 2018; 10():5799-5806. PubMed ID: 30510449
[TBL] [Abstract][Full Text] [Related]
9. A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer.
Ma B; Cao L; Li Y
Math Biosci Eng; 2021 Nov; 18(6):9743-9760. PubMed ID: 34814366
[TBL] [Abstract][Full Text] [Related]
10. Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients.
Li Z; Liu Y; Yi H; Cai T; Wei Y
Front Genet; 2022; 13():947747. PubMed ID: 36246627
[TBL] [Abstract][Full Text] [Related]
11. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.
Jin C; Zhao JS; Huang XQ; Yang XZ; Niu FY; Lin JR; Ma L; Shi YX; Li XS; Jiang P; Gao S; Li F; Song Y
Hepatol Int; 2022 Oct; 16(5):1220-1233. PubMed ID: 35947245
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of stemness-related lncRNA pair signature for predicting prognosis in colorectal cancer.
Thandar M; Zhu Y; Zhang X; Chen Z; Zhao Y; Huang S; Chi P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11815-11828. PubMed ID: 37410143
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer.
Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
Sci Rep; 2023 Jan; 13(1):1333. PubMed ID: 36693898
[TBL] [Abstract][Full Text] [Related]
14. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma.
Cheng X; Zeng Z; Yang H; Chen Y; Liu Y; Zhou X; Zhang C; Wang G
BMC Cancer; 2023 Jan; 23(1):105. PubMed ID: 36717792
[TBL] [Abstract][Full Text] [Related]
15. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
16. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
17. A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer.
Xu C; Li F; Liu Z; Yan C; Xiao J
Front Immunol; 2022; 13():1019764. PubMed ID: 36275644
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
Front Genet; 2022; 13():760514. PubMed ID: 35273635
[No Abstract] [Full Text] [Related]
19. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
20. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
